Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma

Head/Neck

This is a study to determine the clinical benefit (how well the drug works), safety and tolerability of combining CDX-3379 and cetuximab. The study will enroll patients with advanced head and neck squamous cell carcinoma who have previously received cetuximab and progressed.
Head/Neck
II
Gibson, Mike
NCT03254927
VICCHN1891

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: